CD5 CART for the Treatment of Relapsed and Refractory CD5 Hematological Tumors
Clinical trial NCT07234110 · RECRUITING
Trial details
- NCT number
- NCT07234110
- Sponsor
- Institute of Hematology & Blood Diseases Hospital, China
- Status
- RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2025-09-03
- Primary completion
- 2027-05-31
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.